1. Call on Mylan Pharmaceuticals to Reduce Price of Life-Saving EpiPen
Mylan holds a monopoly over the EpiPen product, and thus is able to hike up their prices to whatever standard they prefer. They think there will be no pushback, or if there is, it will be manageable. The "outrage" will die down soon enough. Until someone who can't afford to buy an EpiPen dies instead. Don't let this happen.